🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

37+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 17 of 37 recruiting trials for “Fabry disease”

NARecruitingNCT06095713 ↗

German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa

👨‍⚕️ Eva Brand, MD, PhD, Universitätsklinikum Münster📍 8 sites📅 Started Oct 2023View details ↗
NARecruitingNCT05698901 ↗

Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease

👨‍⚕️ Charles Jia-Yin Hou, Mackay Memorial Hospital📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT05923788 ↗

T1 Mapping in Fabry Disease

👨‍⚕️ SANDRINE LEMOINE, PU-PH📍 2 sites📅 Started Aug 2023View details ↗
Phase 2, PHASE3RecruitingNCT05710692 ↗

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease

🏥 Chiesi Farmaceutici S.p.A.📍 10 sites📅 Started Aug 2023View details ↗
RecruitingNCT06610019 ↗

Cardiovascular Multimodality Imaging Study

👨‍⚕️ Leandro Slipczuk, MD, PhD, Montefiore Medical Center📍 1 site📅 Started May 2023View details ↗
Phase 3RecruitingNCT06081062 ↗

Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease

🏥 ISU Abxis Co., Ltd.📍 3 sites📅 Started Apr 2023View details ↗
Phase 4RecruitingNCT05067868 ↗

A Study of Replagal in Children and Adults With Fabry Disease in India

👨‍⚕️ Study Director, Takeda📍 3 sites📅 Started Nov 2022View details ↗
Phase 1, PHASE2RecruitingNCT05629559 ↗

4D-310 in Adults With Fabry Disease and Cardiac Involvement

👨‍⚕️ Alan H Cohen, MD, 4D Molecular Therapeutics📍 4 sites📅 Started Oct 2022View details ↗
NARecruitingNCT06806813 ↗

Italian Anderson Fabry Disease Cardiovascular Registry

👨‍⚕️ Elena Biagini, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 20 sites📅 Started Jan 2022View details ↗
Enrolling by InvitationNCT05039866 ↗

Long-Term Follow-up of Subjects Who Were Treated With ST-920

👨‍⚕️ Medical Monitor, Sangamo Therapeutics, Inc.📍 13 sites📅 Started Aug 2021View details ↗
NARecruitingNCT04856059 ↗

Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

👨‍⚕️ Kate Hanneman, University Health Network, Toronto📍 1 site📅 Started Jun 2021View details ↗
NARecruitingNCT04440254 ↗

Long Duration Holter ECG in Fabry Disease

👨‍⚕️ Albert HAGEGE, Dr📍 1 site📅 Started May 2021View details ↗
NARecruitingNCT06758648 ↗

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

👨‍⚕️ Roman Günthner, PD Dr., Abteilung für Nephrologie📍 1 site📅 Started Jun 2020View details ↗
RecruitingNCT01581424 ↗

Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study

👨‍⚕️ Chet Whitley, MD, University of Minnesota📍 2 sites📅 Started Oct 2010View details ↗
RecruitingNCT00455104 ↗

Canadian Fabry Disease Initiative (CFDI) National Registry

👨‍⚕️ Michael L West, MD, Queen Elizabeth II Health Sciences Centre (Capital District Health Authority), Halifax, Nova Scotia, Canada📍 5 sites📅 Started Jan 2007View details ↗
NARecruitingNCT00196742 ↗

Fabry Disease Registry & Pregnancy Sub-registry

👨‍⚕️ Study Director, Genzyme, a Sanofi Company📍 20 sites📅 Started Jul 2001View details ↗
RecruitingNCT03362164 ↗

Evaluation of HEArt invoLvement in Patients With FABRY Disease

👨‍⚕️ Peter Nordbeck, MD, PhD, Wuerzburg University Hospital📍 1 site📅 Started Jan 2001View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →